Immune and neurohormonal pathways in chronic heart failure (Q34513186)

2 August 2017

1 reference

title

Immune and neurohormonal pathways in chronic heart failure (English)

1 reference

2 August 2017

1 reference

chronic heart failure

1 reference

Rakesh Sharma

1 reference

2 August 2017

Stefan D Anker

series ordinal

1 reference

2 August 2017

publication date

1 January 2002

1 reference

2 August 2017

published in

Congestive Heart Failure

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

23-8, 48

1 reference

Wasting as independent risk factor for mortality in chronic heart failure

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Insights into the pathogenesis of chronic heart failure: immune activation and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Hyperleptinaemia in chronic heart failure. Relationships with insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Interleukin-6 Spillover in the Peripheral Circulation Increases With the Severity of Heart Failure, and the High Plasma Level of Interleukin-6 Is an Important Prognostic Predictor in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

How are cytokines activated in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Neurohumoral mechanisms involved in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

A placebo-controlled study of growth hormone in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Immunomodulation: a new horizon for medical treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00724.X

10.1111/J.1527-5299.2002.00724.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference